Avoidable delayed treatment U.S. healthcare costs by settings of care 2012
This statistic shows the estimated avoidable healthcare costs due to delayed evidence-based treatment practice in the United States in 2012, by settings of care. In that year, outpatient care created a total of 19.8 billion U.S. dollars in avoidable costs. Total avoidable delayed evidence-based treatment practice healthcare costs reached 39.5 billion U.S. dollars in that year. Expected increase in insurance coverage, chronic diseases, and an aging population may place further stresses on the need for proper medication use to prevent avoidable healthcare costs.